Neuren Pharmaceuticals | NEU - Sales Revenues

Stock Price
11.93
Daily Change
-0.27 -2.21%
Monthly
2.58%
Yearly
3.20%
Q2 Forecast
12.10

Neuren Pharmaceuticals reported AUD42.24M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Clinuvel Pharmaceuticals AUD 36.93M 22.44M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Genetic Signatures AUD 11.19M 5.56M Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Starpharma Holdings AUD 10.83M 9.12M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025